The cardiovascular and renal functional responses to the 5-HT(1A) receptor agonist flesinoxan in two rat models of hypertension

British Journal of Pharmacology

Volumn 118, Issue 8, 1996, Pages 1891-1898

  Chamienia, Andrzej L ^a,b   Johns, Edward J ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Flesinoxan; Goldblatt hypertensive rat; Renal function; Stroke prone spontaneously hypertensive rat

Indexed keywords

CHLORALOSE; FLESINOXAN; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; URETHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOREGULATION; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DIURESIS; GLOMERULUS FILTRATION RATE; HEART RATE; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY DENERVATION; KIDNEY FUNCTION; KIDNEY NERVE; MALE; MICTURITION; NONHUMAN; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; SODIUM EXCRETION; STROKE; SYMPATHETIC NERVE; URINE VOLUME;

EID: 0029786440     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15621.x     Document Type: Article

References (26)

1. AKPOGOMEH, B.A. & JOHNS, E.J. (1991). The characteristics of alpha-adrenoceptors mediating the renal nerve induced antinatriuresis and antidiuresis in hypertensive rats. J. Hypertens., 9, 373-384.
2. BARAJAS, L., LIU, L. & POWERS, K. (1992). Anatomy of the renal innervation: intrarenal aspects of ganglia of origin. Can. J. Physiol. Pharmacol., 70, 735-749.
3. BAUM, T. & SHROPSHIRE, A.T. (1975). Inhibition of efferent sympathetic nerve activity by 5-hydroxytryptophan and centrally administered 5-hydroxytryptamine. Neuropharmacol. 14, 227-233.
4. 1A receptor agonist, flesinoxan, in anaesthetized normotensive rat. Br. J. Pharmacol., 112, 214-218.
5. 1A receptor agonist flesinoxan; effects of controlled renal perfusion pressure. J. Pharmacol. Exp. Ther., 269, 215-220.
6. DAVIS, G. & JOHNS, E.J. (1994). Baroreceptor and somatic sensory regulation of kidney function in 2K1C Goldblatt rats. J. Physiol., 476, 167-176.
7. 1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat. Eur. J. Pharmacol., 180, 339-349.
8. 1A receptor agonists flesinoxan and 8-hydroxy-2(di-N-propylamino) tetralin in the conscious rat. J. Cardiovasc. Pharmacol., 17, 488-493.
9. GRADIN, K., PETTERSSON, A., HJORTH, S., HENDER, T., ARVIDSSON, L.E. & PERSSON, B. (1985). Cardiovascular effects in the Sprague-Dawley rat of 8-hydroxy-2(di-N-propylamino) tetralin, a selective 5-hydroxytryptamine receptor agonist. J. Pharm. Pharmacol., 37, 263-265.
10. GRANGER, J.P. (1992). Pressure natriuresis: role of renal interstitial hydrostatic pressure. Hypertension, 19, (Suppl. 1), 9-17.
11. JOHNS, E.J. (1991). The physiology and pharmacology of the renal nerves. Pol. Arch. Med. Wewn., 85, 141-149.
12. JOHNS, E.J., LEWIS, B.A. & SINGER, B. (1976). The sodium retaining effect of renal nerve activity in the cat: role of angiotensin formation. Clin. Sci. Molec. Med., 51, 93-102.
13. KATHOLI, R.E., WHITLOW, P.L., WINTERNITZ, S.R. & OPARIL, S. (1982). Importance of the renal nerves in established two kidney one clip Goldblatt hypertension in the rat. Hypertension, 4, (Suppl. II), II-166-II-174.
14. KOPP, U.C. (1993). Renorenal reflexes in hypertension. J. Hypertens., 11, 765-773.
15. KOPP, U.C. & BUCKLEY-BLEILER, R.L. (1989). Impaired renorenal reflexes in two kidney, one clip hypertensive rats. Hypertens., 14, 445-452.
16. KOPP, U.C., SMITH, L.A. & DIBONA, G.F. (1987). Impaired renorenal reflexes in spontaneously hypertensive rats. Hypertens., 9, 69-75.
17. LUDBROOK, J. (1994). Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc. Res., 28, 303-311.
18. LUNDIN, S., RICKSTEN, S.E. & THOREN, P. (1984). Renal sympathetic activity in spontaneously hypertensive rats and normal controls, as studied by three different methods. Acta Physiol. Scand., 120, 265-272.
19. LUNDIN, S. & THOREN, P. (1982). Renal function and sympathetic activity during mental stress in nomotensive and spontaneously hypertensive rats. Acta. Physiol. Scand., 115, 115-124.
20. PANFILOV, V.V. & REID, J.L. (1994). Brain and autonomic mechanisms in hypertension. J. Hyptens., 12, 337-345.
21. 2-adrenoceptor agonists in anaesthetized cats. Br. J. Pharmacol., 98, 1157-1164.
22. RAMAGE, A.G., WOUTERS, W. & BEVAN, P. (1988). Evidence that the novel antihypertensive agent, flesinoxan, causes differential sympathoinhibition and also increases vagal tone by a central action. Eur. J. Pharmacol., 151, 373-379.
23. ROMAN, R.J. & COWLEY, A.W.J. (1985). Characterization of a new model for a study of pressure-natriuresis in a rat. Am. J. Physiol., 248, F190-F198.
24. 1-Adrenoceptor subtypes mediating adrenergic vasoconstriction in kidney of two kidney, one-clip Goldblatt and deoxycorticosterone acetate-salt hypertensive rats. J. Cardiovasc. Pharmacol., 24, 420-428.
25. WYSS, J.M., OPARIL, S. & SRIPAIROJTHIKOON, W. (1992). Neural control of the kidney: Contribution to hypertension. Can. J. Physiol. Pharmacol, 70, 759-770.
26. WOUTERS, W., TULP, M.T.M. & BEVAN, P. (1988). Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors. Eur. J. Pharmacol., 149, 213-223.